Nutex Health, Inc.

NASDAQ:NUTX

Medical - Healthcare Information Services

Healthcare
$172.74 +1.94%

+$2.84 today

Market cap
$1.19B
Beta
2.06
P/E (TTM)
10.4
EPS (TTM)
$14.38
52W Low $77.21High $193.07

Volume 0.16M

Average 0.17M

NUTX Sales of Investments

Cash received from selling or redeeming investments.

Nutex Health, Inc.NASDAQ: NUTX

Sales of Investments · Q1 FY2026 · quarter ended Mar 2026

Sales of investments outflow grows to $0

Q1 FY2026 sales of investments was $0, compared with $0 a year earlier. Trailing-twelve-month sales of investments was -$1.35M.

Context

  • Sales of investments amounted to 0.2% of revenue in FY2025, up 0.2 pp from a year earlier.
  • Sales of investments increased in 1 of the last 3 fiscal years.
  • FY2025 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly sales of investments holds near $0 or moves back toward the trailing-twelve-month quarterly average of -$336.25K.

Sources:Cash FlowText generated from reported figures; not investment advice.

Latest quarterMar 2026
$0+100.0% QoQ
Last fiscal yearDec 2025
$1.6M— YoY
LTMMar 2026
-$1.35M— YoY
Sales of Investments past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter———
1 year———
3-year CAGR———
5-year CAGR——
10-year CAGR——

Sales of Investments history

USD · from the cash flow

Latest · FY2025
1.6M USD
Year-over-year change
—

Sales of Investments vs competitors

How NUTX compares with its peers on the latest reported figures

  • NUTX's LTM Mar 2026 sales of investments of $1.35M is the 7th largest of the 11 companies compared; the peer median is $13.3M.
  • Sales of investments amounts to 0.2% of revenue for NUTX, versus a peer median of 0.2%.
NUTX Competitors Peer median
Sales of Investments for NUTX and competitors
Company Period LTM YoY 3-year CAGR% of revenue
AGLAgilon Health, Inc.LTM Mar 2026$180.96M +7.9%+54.5%3.1%
CYHCommunity Health Systems, Inc.LTM Mar 2026$145M +59.3%+3.8%0.7%
THCTenet Healthcare CorporationLTM Jun 2026$107M +28.9%+7.0%0.5%
EHCEncompass Health CorporationLTM Jun 2026$87.6M -23.8%—1.4%
ASTHAstrana Health, Inc.LTM Mar 2026$15M +11996.8%-21.9%0.4%
UHSUniversal Health Services, Inc.LTM Jun 2026$11.6M +269.8%—0.1%
NUTXNutex Health, Inc.LTM Mar 2026$1.35M ——0.2%
CONConcentra Group Holdings Parent, Inc.LTM Sep 2026$0 ——0.0%
SGRYSurgery Partners, Inc.LTM Sep 2026$0 ——0.0%
ARDTArdent Health Partners, LLCLTM Mar 2026$0 ——0.0%
INNVInnovAge Holding Corp.LTM Mar 2026$0 ——0.0%
Peer median (excluding NUTX) $13.3M+44.1%+5.4%0.2%

Competitors are the stored peer set for NUTX. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Cash Flow Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Net Income168.53M(432.74M)(43.42M)95.27M180.36M
Depreciation & Amortization7.66M13.13M17.59M18.97M20.53M
Deferred Income Tax05M(5.71M)(13.13M)17.08M
Stock-Based Compensation0189.58K2.84M16.63M117M
Change in Working Capital2.75M64.32M(1.66M)(104.4M)(87.74M)
Accounts Receivables(6.62M)58.08M(4.58M)(173.41M)(89.32M)
Inventory(1.09M)(719.11K)142.7K540.77K(16K)
Accounts Payables6.27M9.69M(2.25M)(10.72M)37.85M
Other Working Capital4.2M(2.73M)5.03M79.19M(36.26M)
Other Non-Cash Items(5.51M)400.71M31.62M9.81M902K
Operating Cash Flow173.43M50.61M1.26M23.15M248.13M
Capital Expenditures(36.93M)(14.63M)(9.5M)(2.3M)(2.53M)
Acquisitions (Net)(48.85K)10.3M(1.74M)(361.33K)0
Purchases of Investments00000
Sales of Investments00001.6M
Other Investing Activities0000(4.31M)
Investing Cash Flow(36.98M)(4.34M)(11.24M)(2.67M)(5.24M)
Debt Repayment(3.22M)(5.59M)2.65M(7.4M)(19.44M)
Common Stock Issued04.76M09.2M0
Common Stock Repurchased0000(5M)
Dividends Paid(144.34M)(51.23M)(5.21M)(6.44M)(74.28M)
Other Financing Activities21.71M3.93M298.03K5.73M767K
Financing Cash Flow(125.85M)(48.13M)(2.27M)1.09M(97.95M)
Effect of Forex Changes00000
Net Change in Cash10.6M(1.86M)(12.25M)21.58M144.93M
Free Cash Flow136.51M35.97M(8.24M)20.85M245.6M

Nutex Health, Inc.

NASDAQ:NUTX

Intrinsic Alpha fair value

Locked

Current Price

$172.74

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.